For people with schizophrenia hospitalized after a psychotic episode, getting a long-acting antipsychotic injection works far better than pills to keep them from returning to hospital care. That's the ...

Adjunctive treatment with the atypical antipsychotic pimavanserin (Nuplazid, Acadia Pharmaceuticals) is associated with significant improvement in patients with schizophrenia who have predominantly ...

Please provide your email address to receive an email when new articles are posted on . Compared with antipsychotics alone, the addition of evenamide improves treatment-resistant schizophrenia at 6 ...

In a previous article, I made the case that little has changed within the antipsychotic drug landscape over the past 70 years since the only effective medications for the treatment of schizophrenia ...

As the Centers for Medicare & Medicaid Services continues its rapid-fire audits of schizophrenia diagnosing, some providers and quality experts are questioning why the agency hasn’t done more to ...

File photo: Dr. Jeanie Tse, chief medical officer at the Institute for Community Living, administers antipsychotic medication to a patient living with schizophrenia in her home, Wednesday, May 6, 2020 ...

No individual antipsychotic was associated with better cognitive outcomes than placebo in patients with schizophrenia spectrum disorders (SSD), according to a systematic review and network ...

The US Food and Drug Administration (FDA) has approved Cobenfy (Bristol Myers Squibb), a first-in-class antipsychotic approved for schizophrenia. The drug targets cholinergic receptors as opposed to ...

Panelists discuss how negative symptoms like lack of motivation, social withdrawal, and impaired expression significantly impact patients’ ability to maintain relationships and employment, ...

Most people with schizophrenia are prescribed antipsychotic medications that improve many of these symptoms. Researchers hypothesized that these medications may also reduce the risk of a motor vehicle ...